World Wires · story 125552 · corroborated · 1 source(s)

Chimeric antigen receptor T cell therapy targeting CD94 for cytotoxic T/NK cell malignancies

Chimeric antigen receptor (CAR) T cell therapy against pan-B-cell antigens is highly effective, but analogous approaches for T-cell lymphomas risk prolonge

Open in the desk

Coverage

What this site indexes